Home > Insider Trading > Filing (0001140361-17-002196)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
70487	National Research Corp	NRCIA/B	Services-Commercial Physical & Biological Research (8731)	470634000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1053133	D. Michael Hays	C/O National Research Corporation 1245 &Quot;Q&Quot; Street Lincoln NE 68508	Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2017-01-13	10,000	$18.55	5,754,250	No	4	S	Direct
Class A Common Stock	Disposition	2017-01-17	4,296	$18.32	5,749,954	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	138,970	Indirect	By Spouse
Class A Common Stock	75	Indirect	By Spouse & Daughter Jt
Class B Common Stock	1,973,205	Direct
Class B Common Stock	125	Indirect	By Spouse
Class B Common Stock	12	Indirect	By Spouse & Daughter Jt

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Employee Stock Option (right to buy)	$7.59	2018-01-04	21,633	21,633	Direct
Class A Common Stock	Employee Stock Option (right to buy)	$8.12	2019-01-05	20,109	20,109	Direct
Class A Common Stock	Employee Stock Option (right to buy)	$6.29	2020-01-05	26,481	26,481	Direct
Class A Common Stock	Employee Stock Option (right to buy)	$9.14	2021-01-05	17,745	17,745	Direct
Class A Common Stock	Employee Stock Option (right to buy)	$10.75	2022-01-05	14,949	14,949	Direct
Class A Common Stock	Employee Stock Option (right to buy)	$14.50	2023-01-07	10,938	10,938	Direct
Class A Common Stock	Employee Stock Option (right to buy)	$18.80	2024-01-07	2,904	2,904	Direct
Class A Common Stock	Employee Stock Option (right to buy)	$13.17	2025-01-06	10,014	10,014	Direct
Class A Common Stock	Employee Stock Option (right to buy)	$15.23	2026-01-05	9,145	9,145	Direct
Class A Common Stock	Employee Stock Option (right to buy)	$18.80	2027-01-04	7,478	7,478	Direct
Class B Common Stock	Employee Stock Option (right to buy)	$21.50	2022-01-05	2,491	2,491	Direct
Class B Common Stock	Employee Stock Option (right to buy)	$27.13	2023-01-07	1,823	1,823	Direct
Class B Common Stock	Employee Stock Option (right to buy)	$34.15	2024-01-07	266	266	Direct
Class B Common Stock	Employee Stock Option (right to buy)	$35.48	2025-01-06	1,669	1,669	Direct
Class B Common Stock	Employee Stock Option (right to buy)	$34.00	2026-01-05	1,524	1,524	Direct
Class B Common Stock	Employee Stock Option (right to buy)	$40.54	2027-01-04	1,246	1,246	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-01-04	21,633	21,633	Direct
2019-01-05	20,109	20,109	Direct
2020-01-05	26,481	26,481	Direct
2021-01-05	17,745	17,745	Direct
2022-01-05	14,949	14,949	Direct
2023-01-07	10,938	10,938	Direct
2024-01-07	2,904	2,904	Direct
2025-01-06	10,014	10,014	Direct
2026-01-05	9,145	9,145	Direct
2027-01-04	7,478	7,478	Direct
2022-01-05	2,491	2,491	Direct
2023-01-07	1,823	1,823	Direct
2024-01-07	266	266	Direct
2025-01-06	1,669	1,669	Direct
2026-01-05	1,524	1,524	Direct
2027-01-04	1,246	1,246	Direct

Footnotes

The price in Column 4 is a weighted average price. The prices actually received ranged from $18.70 to $18.20. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
The price in Column 4 is a weighted average price. The prices actually received ranged from $18.10 to $18.45. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
The reporting person disclaims beneficial ownership of these shares.
This option became fully exercisable on January 4, 2013.
This option became fully exercisable on January 5, 2014.
This option became fully exercisable on January 5, 2015.
This option became fully exercisable on January 5, 2016.
This option became fully exercisable on January 5, 2017.
This option becomes fully exercisable on January 7, 2018.
This option becomes fully exercisable on January 7, 2019.
This option becomes fully exercisable on January 6, 2020.
This option becomes fully exercisable on January 5, 2021.
This option becomes fully exercisable on January 4, 2022.